GeneDx, a US-based genetic testing laboratory, has introduced a new suite of genetic tests for inherited cancer, including breast and colon cancer. To be marketed under OncoGeneDx brand, the new suite of genetic tests include a 26-gene ...
Tags: Genetic Tests, Inherited Cancer
Israel-based Given Imaging has secured regulatory clearance in Japan for its PillCam COLON, a video capsule that can help in the diagnosis of colonic disease in patients who are unable or unwilling to undergo colonoscopy. Given Imaging ...
Tags: Given Imaging, Capsule
ARUP Laboratories, a US-based national reference laboratory, has developed a blood-based test for identifying patients with previously undetected colorectal cancer. Designed as an alternative to colonoscopy, the Septin 9 methylated DNA ...
Navidea Biopharmaceuticals has collaborated with Maimonides Medical Center to find the use of Lymphoseek (technetium Tc 99m tilmanocept) injection for lymphatic mapping in colorectal cancer. The investigator-initiated study will be ...
Tags: Navidea, Medical Center, medical market
Navidea Biopharmaceuticals has jouned forces with Maimonides Medical Centre to investigate Lymphoseek injections as a potential treatment for colorectal cancer. Dr. Danny Sherwinter, surgeon and the director of the Department of Minimally ...
Lantheus Medical Imaging will receive $300,000 Massachusetts-Israel Innovation Partnership (MIIP) grant, upon signing a collaboration agreement with Check-Cap. The grant will be used by the companies to develop and manufacture new 3-D ...
Tags: Check-Cap, 3-D Imaging Capsule, colon cancer
Agendia, a developer of genomic-based diagnostic products, has unveiled ColoPrint microarray-based 18-gene expression signature. The ColoPrint assay provides critical additional information for treatment decisions for stage II colon ...
Tags: ColoPrint, Agendia, colon cancer patients
The molecular cancer diagnostics company, Agendia, has introduced ColoPrint microarray-based 18-gene expression assay. The ColoPrint assay is designed for predicting the risk of distant recurrence for stage II colon cancer patients who ...
Tags: molecular cancer diagnostics, expression assay, cancer diagnostics
More than 80 percent of people with pancreatic cancer are diagnosed after the cancer has metastasized, and by then the prognosis for long-term survival is dismal. However, surgeons and scientists at the University of California-San Diego ...
Tags: fluorescent light
More than 80 percent of people with pancreatic cancer are diagnosed after the cancer has metastasized, and by then the prognosis for long-term survival is dismal. However, surgeons and scientists at the University of California-San Diego ...
Tags: Market View, fluorescent light